Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Cleveland, Ohio 44106


Purpose:

Subjects must be 18- 75 years old and have a history of both inflammatory bowels disease (Crohn's or ulcerative colitis) and pyoderma gangrenosum. This is a 6 month open label study of an intravenous (IV) medication. Visits occur every 2 weeks initially, then every 1-2 months later in the study.


Criteria:

Inclusion Criteria: - Must Be ages 18-75 - Must have both inflammatory bowel disease and moderate to severe pyoderma gangrenosum - Must never have received Infliximab for the treatment of pyoderma gangrenosum Exclusion Criteria: - Have had any previous treatment with monoclonal antibodies other than infliximab used to treat IBD or antibody fragments. - Have a history of serious infections


NCT ID:

NCT00791557


Primary Contact:

Principal Investigator
Neil J Korman, MD.PhD
University Hospitals Case Medical Center


Backup Contact:

N/A


Location Contact:

Cleveland, Ohio 44106
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.